Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Palisade Bio Q2 EPS $(0.12) Up From $(4.10) YoY

Palisade Bio Q2 EPS $(0.12) Up From $(4.10) YoY

Palisade Bio (NASDAQ:PALI) reported quarterly losses of $(0.12) per share. This is a 97.07 percent increase over losses of $(4.10) per share from the same period last year.

byBenzinga Newsdesk

August 15, 2022

1 minute read

Palisade Bio (NASDAQ:PALI) reported quarterly losses of $(0.12) per share. This is a 97.07 percent increase over losses of $(4.10) per share from the same period last year.

Citigroup Maintains Buy on Monday.Com, Raises Price Target to $169

By Benzinga Newsdesk

February 14, 7:46 AM

Citigroup analyst Steven Enders maintains Monday.Com (NASDAQ:MNDY) with a Buy and raises the price target from $132 to $169.

MNDY

MediPharm Labs FY22 Revenue Grows Slightly To $16.3M

By Vuk Zdinjak

March 31, 11:14 AM

MediPharm Labs Corp. (TSX:LABS) (OTCQX: MEDIF) (FSE:MLZ) FY 2022 revenue was CA$22.1 million ($16.3 million), an increase of 1.8% compared to CA$21.7 million in FY 2021.

MEDIF